← Open Payments lookup

MICHAEL SUSANO: Open Payments

NPI 1063440105 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$844 in 59 payments from 8 companies in 2025. Trend: 2023 $604 · 2024 $615 · 2025 $844

Food & beverage: $811Education: $33
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.14$226
Alkermes, Inc.20$192
E.R. Squibb & Sons, L.L.C.11$162
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$101
Otsuka America Pharmaceutical, Inc.4$89
ABBVIE INC.2$36
Vanda Pharmaceuticals Inc.1$19
Teva Pharmaceuticals USA, Inc.1$18

Products named: INGREZZA, ARISTADA, COBENFY, CAPLYTA, ABILIFY ASIMTUFII, REXULTI, VRAYLAR, LYBALVI.

Industry payments across LA — which companies pay providers there.